Androgen receptor as a target in androgen-independent prostate cancer.
about
The molecular mechanisms of coactivator utilization in ligand-dependent transactivation by the androgen receptorThe beta-catenin binding protein ICAT modulates androgen receptor activityMelanoma antigen gene protein MAGE-11 regulates androgen receptor function by modulating the interdomain interactionSmall molecule screening reveals a transcription-independent pro-survival function of androgen receptor in castration-resistant prostate cancerStructure-activity relationship for thiohydantoin androgen receptor antagonists for castration-resistant prostate cancer (CRPC)Identification of androgen-coregulated protein networks from the microsomes of human prostate cancer cellsGaleterone for the treatment of advanced prostate cancer: the evidence to dateThe convergence of DNA damage checkpoint pathways and androgen receptor signaling in prostate cancerAntineoplastic effect of beta-elemene on prostate cancer cells and other types of solid tumour cellsModulators of prostate cancer cell proliferation and viability identified by short-hairpin RNA library screeningLigand-independent activation of androgen receptors by Rho GTPase signaling in prostate cancerActivation of the DNA-dependent protein kinase stimulates nuclear export of the androgen receptor in vitro.Genomic androgen receptor-occupied regions with different functions, defined by histone acetylation, coregulators and transcriptional capacityProteomic identification of 14-3-3 sigma as a common component of the androgen receptor and the epidermal growth factor receptor signaling pathways of the human prostate epithelial cell line M12.Androgen regulation of the androgen receptor coregulators.New developments in the medical management of prostate cancer.Efficacy of c-Met inhibitor for advanced prostate cancer.Cyclin D1 splice variants: polymorphism, risk, and isoform-specific regulation in prostate cancer.The androgen receptor recruits nuclear receptor CoRepressor (N-CoR) in the presence of mifepristone via its N and C termini revealing a novel molecular mechanism for androgen receptor antagonists.Dynamic methylation of histone H3 at lysine 4 in transcriptional regulation by the androgen receptor.ZMIZ1 preferably enhances the transcriptional activity of androgen receptor with short polyglutamine tract.Decreased expression and androgen regulation of the tumor suppressor gene INPP4B in prostate cancer.ART-27, an androgen receptor coactivator regulated in prostate development and cancer.Characterization of androgen receptor structure and nucleocytoplasmic shuttling of the rice field eel.Androgen receptor antagonists in castration-resistant prostate cancer.FKBP51 and Cyp40 are positive regulators of androgen-dependent prostate cancer cell growth and the targets of FK506 and cyclosporin A.Testosterone regulates cell proliferation in aggressive fibromatosis (desmoid tumour).Crosstalking between androgen and PI3K/AKT signaling pathways in prostate cancer cells.Androgen receptor remains critical for cell-cycle progression in androgen-independent CWR22 prostate cancer cellsA novel nuclear role for the Vav3 nucleotide exchange factor in androgen receptor coactivation in prostate cancerMathematical modeling of prostate cancer progression in response to androgen ablation therapy.Mechanisms mediating androgen receptor reactivation after castration.A promoting role of androgen receptor in androgen-sensitive and -insensitive prostate cancer cells.Identification of novel androgen receptor target genes in prostate cancer.Androgen signaling is a confounding factor for β-catenin-mediated prostate tumorigenesis.The androgen receptor and mechanisms for androgen independence in prostate cancer.Expression of SOCS1 and the downstream targets of its putative tumor suppressor functions in prostate cancer.The cyclin D1b splice variant: an old oncogene learns new tricks.Targeting of Androgen Receptor Expression by Andro-miRs as Novel Adjunctive Therapeutics in Prostate Cancer.Regulation of Akt/FOXO3a/GSK-3beta/AR signaling network by isoflavone in prostate cancer cells
P2860
Q24316455-D450ED85-7A0A-4C9F-A8FA-24B9309B011DQ24337124-A94CE2F5-4FD7-434B-90F9-AF6DFD6C0CC8Q24556963-5F5338E8-8883-4FB2-B23F-B69E687CCE02Q24620356-540309C7-83E7-4F81-9586-623449588018Q24635639-AB72E3DA-404F-4F21-9EE6-410820A37C32Q24806811-4BAC99C8-1EE5-4D54-9CE4-025622645FB0Q26739887-1D88EAE0-2EB8-4E0C-8B2A-D99333FA3385Q27014101-AC2B4DDD-31C0-4ED2-A9DB-53703E7659A9Q28288947-1AB9DFB8-0988-4B4C-A2C3-A3B6702F8534Q28482249-14903E22-5CB7-415D-9DCB-A91FF2AE7EC5Q30440162-A875161C-863C-4EC1-81EE-5206F21F5660Q30445593-013E4127-37B8-41E0-917F-C4ADF5154FC9Q30853584-5F25FCDC-B268-4689-8090-511C64530917Q33205584-E78BCBCF-B451-4A34-AA1D-A1957AAC186DQ33357016-282D35D6-8765-4B19-9475-9327135CC435Q33566738-4C1D2427-A0A1-4D7E-A05F-A96524290098Q33718726-36D1C511-A190-452B-AA28-525F7114C2FAQ33768593-31B39F99-9912-49B0-8C61-32ACD63B454FQ33983786-FDE37167-4ABB-413C-9182-F6F8F38E15BBQ33988138-3A8B82D6-9B8F-4369-98C5-D91DA08045DCQ34031869-C87CCFB8-C145-47F8-B4D1-00E66AFDD6E9Q34158474-90B72F69-E523-4706-8CC8-BAC0BACEAF49Q34288622-64E2B1F5-F1A3-461F-86ED-AE1A23BCDC4CQ34299330-06DBA0B4-B11D-4764-A7AE-AFD5F05C6434Q34323656-BCE26F39-4A27-49E6-A47C-3377976A2951Q34580343-D896CBBE-FBF3-48C3-AB4D-04E9736D1A3EQ35006864-02EBE236-7E81-494B-9176-5226CE9D9558Q35048965-73217D1D-458C-4B99-8D09-7089AF941DBEQ35221988-7A8828CC-2748-4E4B-BBCC-9B8ABBF0BA35Q35465076-09F25B71-0C94-4FF4-BCB2-CBECD4735FD3Q35621205-931B662B-25D6-4142-8A96-059E5D96E7E0Q35633454-8F7FA5C4-6FBE-4A16-88A6-78BA7A99925CQ35829355-8398853B-8F74-4E3B-9097-CDF48FF4424AQ35865261-7D2A24B1-10E9-4F42-90D4-DF3D224BC56BQ36189798-B2A217AB-FA0D-462C-B619-AAFA97F76494Q36276350-C71B398C-C4F5-4CEB-8B36-24F305C855FCQ36290408-FD276A92-7D9D-4EA0-A41F-1F9E3C6D6E09Q36545151-D272EBD3-3CB7-4DBB-874F-231E7724CDCEQ36575243-A34D5236-A1C9-465F-BEE8-595F06254351Q36924212-8FD5C420-D519-4962-ABAA-1FB355D392E6
P2860
Androgen receptor as a target in androgen-independent prostate cancer.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Androgen receptor as a target in androgen-independent prostate cancer.
@ast
Androgen receptor as a target in androgen-independent prostate cancer.
@en
Androgen receptor as a target in androgen-independent prostate cancer.
@nl
type
label
Androgen receptor as a target in androgen-independent prostate cancer.
@ast
Androgen receptor as a target in androgen-independent prostate cancer.
@en
Androgen receptor as a target in androgen-independent prostate cancer.
@nl
prefLabel
Androgen receptor as a target in androgen-independent prostate cancer.
@ast
Androgen receptor as a target in androgen-independent prostate cancer.
@en
Androgen receptor as a target in androgen-independent prostate cancer.
@nl
P1433
P1476
Androgen receptor as a target in androgen-independent prostate cancer.
@en
P2093
Steven P Balk
P304
132-8; discussion 138-9
P356
10.1016/S0090-4295(02)01593-5
P407
P433
P577
2002-09-01T00:00:00Z